explore -WSS

explore

author：Wikipedia 2025-09-05 11:25:19 - browse：53

A page of braille. -- health tech coverage from STAT — Adobe

Katie Keim was diagnosed with type 1 diabetes in 1967 when she was eight, well before the era of insulin pumps or even reliable home testing. The condition started eating away at her vision 20 years later. By the time she was 36, her sight was completely gone.

Keim had lived an independent life as a child despite her illness. Her summers were spent exploring oceans with her family, not at diabetic summer camps. Blindness, though, changed every aspect of her life — including her ability to manage her diabetes. Her first insulin pump had tactile buttons, but all the pumps that came to replace it had digital screens.

“Blind people cannot independently and safely manage our lives through the technology that’s available in home medical devices,” Keim said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： FDA early review: GLP

knowledge

WSS

Ukraine seeks to reclaim its role as a hub for clinical trials

Abridge raises $150m as clinical notes automation market heats up

Researchers tackle phage therapy hurdles for wider adoption

Abridge raises $150m as clinical notes automation market heats up

In 'major milestone,' FDA approves first cell therapy for solid tumors

Life science postdocs should get big pay hike, NIH panel says

focus

explore

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Cancer drug shortages should be causing more outrage

A preacher's new calling: Diversifying neuroscience research

BioMarin wins approval for gene therapy to treat hemophilia A

Merck to acquire Harpoon Therapeutics for $680 million

Drug repurposing or repositioning? The language matters

Congress may force more Covid

At least 13 dead in Texas as scorching temps continue

Flagship Pioneering startup Sonata Therapeutics lays off 21

focus

Hospitals are piloting generative AI tools as regulators play catch

Life science postdocs should get big pay hike, NIH panel says

Boston Scientific acquires urology company Axonics for $3.7 billion

In 'major milestone,' FDA approves first cell therapy for solid tumors

Study suggests new cause of Down syndrome: cells linked to aging

Male doctors called my cancer incurable. A female doctor showed it wasn't

knowledge

Wikipedia

knowledge

focus